|
|
B S Horowitz, I J Goldberg, J Merab, T M Vanni, R Ramakrishnan, H N Ginsberg
J Clin Invest. 1993;
91(4):1743
doi:10.1172/JCI116384
Abstract |
Full text
| PDF

P
lasma levels of HDL apo A-I are reduced in individuals with low HDL cholesterol (HDL-C) concentrations as a result of increased fractional catabolic rates (FCRs). To determine the basis for the high apo A-I FCRs, seven subjects with low HDL-C levels (31.0 +/- 4.3 mg/dl) were compared with three subjects with high HDL-C levels (72.0 +/- 4.5 mg/dl). Each subject received autologous HDL that was labeled directly by the iodine-monochloride method (whole-labeled) and autologous HDL that was labeled by exchange with homologous radiolabeled apo A-I (exchange-labeled). Blood was obtained for 2 wk, specific activities determined, and FCRs (d-1 +/- SD) estimated. In every subject, whether in the low or high HDL-C group, the exchange-labeled FCR was greater than the whole-labeled FCR. The exchange-labeled FCR was higher in the low HDL-C group (0.339 +/- 0.043) versus the high HDL-C group (0.234 +/- 0.047; P < 0.009). The whole-labeled FCR was also greater in the low HDL-C group (0.239 +/- 0.023) versus the high HDL-C group (0.161 +/- 0.064; P < 0.02). In addition, in both low and high HDL groups ultracentrifugation resulted in more radioactivity in d > 1.210 (as percentage of total plasma counts per minute) with the exchange-labeled tracer than with the whole-labeled tracer (12.55 +/- 4.95% vs. 1.02 +/- 0.38%; P < 0.003). With both HDL tracers, more radioactivity was found in d > 1.210 in the low versus the high HDL-C groups. When apo A-I catabolism was studied by perfusing isolated rabbit kidneys with whole-labeled HDL, there was twice as much accumulation (cpm/g cortex) of HDL apo A-I isolated from subjects with low HDL-C than from subjects with high HDL-C (P < 0.0025). Finally, HDL that had been isolated from subjects with high levels of HDL-C was triglyceride enriched and exposed to partially purified lipases before perfusion through kidneys. Threefold more apo A-I from modified HDL accumulated in the cortex compared with the unmodified preparation (P < 0.007). The results of these in vivo and ex vivo studies indicate that individuals with low HDL-C levels have more loosely bound, easily exchanged apo A-I and that this exchangeable apo A-I is more readily cleared by the kidney.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(51)
| Title and authors |
Publication |
Year |
Comprehensive Physiology
Henry N. Ginsberg, Ira J. Goldberg
|
Comprehensive Physiology
|
2011 |
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. J. Chapman, H. N. Ginsberg, P. Amarenco, F. Andreotti, J. Boren, A. L. Catapano, O. S. Descamps, E. Fisher, P. T. Kovanen, J. A. Kuivenhoven, P. Lesnik, L. Masana, B. G. Nordestgaard, K. K. Ray, Z. Reiner, M.-R. Taskinen, L. Tokgozoglu, A. Tybjaerg-Hansen, G. F. Watts
|
European Heart Journal
|
2011 |
Imaging apolipoprotein AI in vivo
Renuka Sriram, Jens O. Lagerstedt, Jitka Petrlova, Haris Samardzic, Ulrike Kreutzer, Hongtao Xie, George A. Kaysen, Jean F. Desreux, David Thonon, Vincent Jacques, Martha Van Loan, John C. Rutledge, Michael N. Oda, John C. Voss, Thomas Jue
|
NMR Biomed.
|
2011 |
Therapies for diabetic dyslipidaemia
D. S. H. Bell, F. Al Badarin, J. H. O’Keefe
|
Diabetes, Obesity and Metabolism
|
2011 |
Proteomic detection of nitroproteins as potential biomarkers for cardiovascular disease
Mutay Aslan, Serdar Dogan
|
Journal of Proteomics
|
2011 |
Abnormal Metabolism
|
High-Density Lipoproteins Structure Metabolism Function and Therapeutics
|
2011 |
The effect of PPAR-α agonism on apolipoprotein metabolism in humans
Ashish Shah, Daniel J. Rader, John S. Millar
|
Atherosclerosis
|
2010 |
Obesity and Dyslipidemia
Remco Franssen, Houshang Monajemi, Erik S.G. Stroes, John J.P. Kastelein
|
Endocrinology & Metabolism Clinics of North America
|
2008 |
Lipoprotein metabolism in chronic renal insufficiency
Jeffrey M. Saland, Henry N. Ginsberg
|
Pediatr Nephrol
|
2007 |
Association of heterozygous familial hypercholesterolemia with smaller HDL particle size
Jean-Charles Hogue, Benoît Lamarche, Daniel Gaudet, André J. Tremblay, Jean-Pierre Després, Jean Bergeron, Claude Gagné, Patrick Couture
|
Atherosclerosis
|
2007 |
|